...
首页> 外文期刊>Forensic science international >Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, alpha-PHPP and alpha-POP, with 11 newly distributed designer drugs in illegal products
【24h】

Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, alpha-PHPP and alpha-POP, with 11 newly distributed designer drugs in illegal products

机译:表征四种新的名牌药物5-氯代-NNEI,NNEI吲唑类似物,α-PHPP和α-POP,以及11种新发布的非法产品中的名牌药物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Our continuous survey of illegal products in Japan revealed the new distribution of 15 designer drugs. We identified four synthetic cannabinoids, i.e., NNEI (1), 5-fluoro-NNEI (2), 5-chloro-NNEI (3) and NNEI indazole analog (4), and seven cathinone derivatives, i.e., MPHP (5), alpha-PHPP (6), alpha-POP (7), 3,4-dimethoxy-a-PVP (8), 4-fluoro-alpha-PVP (9), a-ethylaminopentiophenone (10) and N-ethyl-4-methyl-pentedrone (11). We also determined LY-2183240 (12) and its 2'-isomer (13), which were reported to inhibit endocannabinoid uptake, a methylphenidate analog, 3,4-dichloromethylphenidate (14), and an MDA analog, 5-APDB (15). No chemical and pharmaceutical data for compounds 3, 4, 6 and 7 had been reported, making this the first report on these compounds.
机译:我们对日本的违禁产品进行的持续调查显示,新分配了15种名牌药物。我们确定了四种合成大麻素,即NNEI(1),5-氟代NNEI(2),5-氯代NNEI(3)和NNEI吲唑类似物(4),以及七个卡西酮衍生物,即MPHP(5), α-PHPP(6),α-POP(7),3,4-二甲氧基-a-PVP(8),4-氟-α-PVP(9),α-乙基氨基五苯酮(10)和N-乙基-4 -甲基戊酮(11)。我们还测定了据报道可抑制内源性大麻素摄取的LY-2183240(12)及其2'-异构体(13),甲基哌甲酯类似物3,4-二氯甲基哌啶酸酯(14)和MDA类似物5-APDB(15 )。没有化​​合物3、4、6和7的化学和药物数据的报道,这是有关这些化合物的第一份报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号